Correlation Between Design Therapeutics and Silo Pharma
Can any of the company-specific risk be diversified away by investing in both Design Therapeutics and Silo Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Design Therapeutics and Silo Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Design Therapeutics and Silo Pharma, you can compare the effects of market volatilities on Design Therapeutics and Silo Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Design Therapeutics with a short position of Silo Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Design Therapeutics and Silo Pharma.
Diversification Opportunities for Design Therapeutics and Silo Pharma
-0.73 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Design and Silo is -0.73. Overlapping area represents the amount of risk that can be diversified away by holding Design Therapeutics and Silo Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Silo Pharma and Design Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Design Therapeutics are associated (or correlated) with Silo Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Silo Pharma has no effect on the direction of Design Therapeutics i.e., Design Therapeutics and Silo Pharma go up and down completely randomly.
Pair Corralation between Design Therapeutics and Silo Pharma
Given the investment horizon of 90 days Design Therapeutics is expected to under-perform the Silo Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Design Therapeutics is 2.28 times less risky than Silo Pharma. The stock trades about -0.19 of its potential returns per unit of risk. The Silo Pharma is currently generating about 0.24 of returns per unit of risk over similar time horizon. If you would invest 99.00 in Silo Pharma on November 5, 2024 and sell it today you would earn a total of 62.00 from holding Silo Pharma or generate 62.63% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Design Therapeutics vs. Silo Pharma
Performance |
| Timeline |
| Design Therapeutics |
| Silo Pharma |
Design Therapeutics and Silo Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Design Therapeutics and Silo Pharma
The main advantage of trading using opposite Design Therapeutics and Silo Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Design Therapeutics position performs unexpectedly, Silo Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Silo Pharma will offset losses from the drop in Silo Pharma's long position.| Design Therapeutics vs. Monte Rosa Therapeutics | Design Therapeutics vs. Werewolf Therapeutics | Design Therapeutics vs. Ikena Oncology | Design Therapeutics vs. Stoke Therapeutics |
| Silo Pharma vs. Rezolute | Silo Pharma vs. Anebulo Pharmaceuticals | Silo Pharma vs. Sino Biopharmaceutical Limited | Silo Pharma vs. Inventiva Sa |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |